2007Applied Journal of General PracticeRequires access

Acanthopanax Senticosus Injection Combined with Lotensin for Microalbuminuria in Patients with Diabetic Nephropathy

Zhan Su

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of Acanthopanax senticosus injection and Lotensin in the treatment of early diabetic nephropathy(DN).Methods Sixty cases with early DN were divided into control group(n=28)and treatment group(n=34)randomly.Both groups were basically treated with the method of reducing blood sugar and lipid,controlling blood pressure,administering with Lotensin and taking low protein diet.The treatment group was additional administered with Acanthopanax senticosus injection.The course of treatment was both 2 to 3 weeks.Results Levels of blood fat(TG and TC)and Urinary albumin excretion(UAE)lowered significantly after treatment in both groups(P0.01),and there was obviously difference between the two groups(P0.05).No side effects were found.Conclusions Lotensin combined with Acanthopanax senticosus injection is an ideal therapy for early DN.

About this research paper

What this paper is about

Objective To observe the clinical effect of Acanthopanax senticosus injection and Lotensin in the treatment of early diabetic nephropathy(DN).Methods Sixty cases with early DN were divided into control group(n=28)and treatment group(n=34)randomly.Both groups were basically treated with the method of reducing blood sugar and lipid,controlling blood pressure,administering with Lotensin and taking low protein diet.The treatment group was additional administered with Acanthopanax senticosus injection.The course of treatment was both 2 to 3 weeks.Results Levels of blood fat(TG and TC)and Urinary albumin excretion(UAE)lowered significantly after treatment in both groups(P0.01),and there was obviously difference between the two groups(P0.05).No side effects were found.Conclusions Lotensin combined with Acanthopanax senticosus injection is an ideal therapy for early DN.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of Acanthopanax senticosus injection and Lotensin in the treatment of early diabetic nephropathy(DN).Methods Sixty cases with early DN were divided into control group(n=28)and treatment group(n=34)randomly.Both groups were basically treated with the method of reducing blood sugar and lipid,controlling blood pressure,administering with Lotensin and taking low protein diet.The treatment group was additional administered with Acanthopanax senticosus injection.The course of treatment was both 2 to 3 weeks.Results Levels of blood fat(TG and TC)and Urinary albumin excretion(UAE)lowered significantly after treatment in both groups(P0.01),and there was obviously difference between the two groups(P0.05).No side effects were found.Conclusions Lotensin combined with Acanthopanax senticosus injection is an ideal therapy for early DN.

Key concepts: Medicine, Microalbuminuria, Diabetic nephropathy, Urology, Blood sugar, Internal medicine, Excretion, Urine

Related papers

Back to paper searchBrowse research topicsOriginal source
Acanthopanax Senticosus Injection Combined with Lotensin for Microalbuminuria in Patients with Diabetic Nephropathy — Research Paper | ScholarLens